„Focusing on IL-6/STAT3 Pathway shows the approach of anti-IL-6 antibody (tocilizumab) in the treatment of multiple hydrocephalus“. Current Opinion 1, no. 01 (Dezember 10, 2021): 15–19. Zugegriffen Oktober 11, 2026. https://currentopinion.be/index.php/co/article/view/14.